The genotype 3-specific hepatitis C virus core protein residue phenylalanine 164 increases steatosis in an in vitro cellular model.
OBJECTIVE
The prevalence and severity of liver steatosis are higher in patients infected with genotype 3 hepatitis C virus (HCV) than in patients infected with other genotypes. HCV core protein is known to affect lipid metabolism, inducing lipid droplet accumulation both in vitro and in vivo. An in vitro cellular model was used to investigate whether an HCV core protein with residues specific to genotype 3 increased this phenomenon.


METHODS
Sequence comparisons for HCV core protein domain II, which is known to interact with lipid droplets, identified the phenylalanine (F) residue at position 164 as the only residue specific to genotype 3. The area covered by lipid droplets in sections of cells producing a wild-type genotype 1a HCV core protein was compared with that in cells producing a Y164F mutant protein.


RESULTS
Cumulative lipid droplet area was significantly greater in sections of cells producing the Y164F mutant HCV core protein than in cells producing the wild-type protein (p<0.001). The frequency of cell sections containing more than 3 mum(2) of lipid droplets, in particular, was higher for the mutant than for the wild-type protein.


CONCLUSIONS
The data provide a molecular explanation for HCV genotype 3-specific lipid accumulation. This difference between genotypes may be due to phenylalanine having a higher affinity for lipids than tyrosine (Y). These observations provide useful information for further studies of the mechanisms involved in HCV-induced steatosis.
Hourioux
C
C
Université François Rabelais, INSERM ERI 19 & CHRU de Tours, 10 boulevard Tonnellé, F-37032 Tours Cedex, France.
Patient
R
R
Morin
A
A
Blanchard
E
E
Moreau
A
A
Trassard
S
S
Giraudeau
B
B
Roingeard
P
P
D000818:Animals; D002478:Cells, Cultured; D006224:Cricetinae; D005234:Fatty Liver / Q000235:genetics*; D005786:Gene Expression Regulation / Q000235:genetics; D005838:Genotype; D016174:Hepacivirus / Q000235:genetics*; D019698:Hepatitis C, Chronic / Q000235:genetics*; D008055:Lipids; D018613:Microscopy, Confocal / Q000379:methods; D008854:Microscopy, Electron / Q000379:methods; D009154:Mutation / Q000235:genetics; D010649:Phenylalanine / Q000235:genetics*; D016415:Sequence Alignment / Q000379:methods; D014758:Viral Core Proteins / Q000235:genetics*
D008055:Lipids; D014758:Viral Core Proteins; C069130:nucleocapsid protein, Hepatitis C virus; D010649:Phenylalanine